That led him to co-found patient focused charity Olivia’s Vision and to become a campaigners for the medicinal cannabis industry by his legal platform to force changes in the listing rules.ĮS: Nick, you’re a rare beast in that you have helped open up a new asset class His interest startedwith his daughter being diagnosed with Uveitis, an auto-immune disease at the age of eight. We talked to Nick Davis of Memery Crystal about what drove his campaign to get the listing rules in London relaxed. Others say that after an uphill battle with the establishment, there is now a growing feeling that London is the right place for the burgeoning cannabis market to raise money to fund medical exploration. But MGC Pharma is the first of what we expect to be many listings on the LSE focussed on the health applications of cannabis and its derivatives.” Research into medical applications of cannabis is still at an early stage. The research concludes that the UK legal cannabis market will be worth some £2.3 billion by 2024.Īlex Brooks, senior analyst at Cannacord Genuity, said: “There’s huge pent-up demand across Europe from patients and doctors, and especially here in the UK. Medicinal cannabis is now legal in 30 states in America with a projected market of $37.9 billion by 2024 according to research by Prohibition Partners who further estimate that in the UK around 340,00 patients will be making use of these treatments by 2024. We are in the early foothills in the UK for acceptance with medicinal cannabis companies and pressure needs to be maintained with the investment industry to allow retail investors to participate in this huge growth sector.” Nick Davis, CEO of Memery Crystal and a campaigning advocate of medicinal use of cannabis said: “Following the successful IPO of MGC I have had calls from Israel, Canada and America with companies wanting to list in the UK. New West End Company BRANDPOST | PAID CONTENTĪttitudes are changing, at last, and after a long struggle.
Tej Kohli & Ruit Foundation BRANDPOST | PAID CONTENT.
0 kommentar(er)
